ELIZABETH HUSHKA: Open Payments
NPI 1043674138 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$24,867 in 66 payments from 10 companies in 2025. Trend: 2023 $3,998 · 2024 $7,603 · 2025 $24,867
Speaker / faculty: $18,444Travel & lodging: $4,924Food & beverage: $1,499
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 44 | $22,798 |
| BridgeBio Pharma, Inc. | 10 | $1,802 |
| Abbott Laboratories | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Hologic Sales and Service, LLC | 1 | $33 |
| SCPHARMACEUTICALS INC. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $15 |
Products named: AMVUTTRA, Attruby, CARDIOMEMS, APTIMA, FUROSCIX, VERQUVO, LEQVIO, FARXIGA.
Industry payments across IL — which companies pay providers there.
